| Particulars |
|
|
|
|
Company Name
| Suven Pharmaceuticals Ltd
|
Year End
| 202403
|
| Full Year |
| Equity (₹ Cr.) |
25.46 |
B.V. (₹) |
86.70 |
| Sales(₹ Cr.) |
1,024.99 |
NP (₹ Cr.) |
272.29 |
| NP Var% |
-35.00 |
Div% |
0.00 |
| CPS(₹) |
12.60 |
EPS (₹) |
10.70 |
| Traded Value(₹ Lakhs) |
191.51 |
52 Week High |
1,359.00 |
| 52 Week Low |
597.00 |
Price BSE |
1,075.00 |
| Price NSE |
1,079.00 |
Market Capital (₹ Cr.) |
27,373.37 |
| P/C Ratio |
85.20 |
P/E Ratio |
100.50 |
| Price Vs.BV |
12.40 |
|
| Latest Quarter |
| Year End |
202412 |
Sales (₹ Cr.) |
275.39 |
| NP(₹ Cr.) |
86.35 |
NP Var % |
65.00 |
| Trailing Twelve Months |
| Year End |
202412 |
Sales |
914.50 |
| OPM |
35.57 |
NP |
247.20 |
| NP Var% |
-26.30 |
EPS |
11.05 |
| PE |
97.31 |
|
|